Skip to main content

Precision Medicine Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021–2026

 

Global Precision Medicine Market is expected to reach the market valuation of US$ 105.64 billion by 2026 expanding at a reasonable CAGR of 9.95% during the forecast period (2021-2026) from US$ 58.66 billion in 2019. Development in precision medicine is occurring at an owing to the effectiveness of this medication. Government bodies such as research institutes and hospitals are also taking part for its development.

Healthcare is changing rapidly. Several technologies are being introduced every year to decrease the mortality rate. Currently, a transition has been witnessed from the traditional reactive medicine that was based on symptoms, diagnosis and treatment to a system that targets the disease much earlier it occurs. Precision Medicine is that new way of thinking. The major principles on which the precision medicine is based involves prediction, prevention, personalization, and participation. The growing attention toward precision medicine is directed by a fundamental shift from the ‘one size fits all’ paradigm for treatment of patients with conditions or predisposition to diseases. Driven by these, numerous national as well as international genome projects have been initiated to reap the benefits of precision medicine.

Request for Sample of the report browse through- https://univdatos.com/request_form/form/331

According to an analysis, the topmost 10 highest-grossing drugs in the U.S. merely help between 1 in 4 to 1 in 25 of the patients who administer them. This estimate highlights the lack of specificity for the drugs that are in currently in use and provides the opportunity that exists for highly targeted precision medicines. Gene sequencing is a major part of precision medicine as it is genome based. Advances in next generation sequencing (NGS) technologies have resulted in an exceptional proliferation and surge of genomic sequence data.

Precision medicine is not only based on pharmacology. There are numerous components of this type of medicine as they are highly specific to the genome of a group of individuals. Big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others are some of the technologies that are required for the precision medicine development. Bioinformatics and gene sequencing are required for producing genomic data, as genomic data is necessary for the drug development. Big data analytics is used for the analysis of the data produced. Oncology, respiratory diseases, central nervous system disorders, immunology and genetic diseases are some of the mostly studied diseases in this area. More than 50% of the precision medicine research is done on oncology, as it is one of the burning topics in healthcare.

For a detailed analysis of the automation in Precision Medicines browse through - https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026 

There are several end-users of precision medicine. hospitals & clinics, pharmaceuticals, diagnostic companies, Healthcare-IT firms, and others are some of the major end users. Pharmaceutical companies are developing precision medicine by collaborating with several players. Amgen, a leading biotechnology company and Syapse announced a precision medicine collaboration in oncology. These collaborations act as the ‘X factor’ for the thriving industry. Genomic sequencing also plays a crucial part in precision medicine development as genomic sequencing and biomedical informatics in the laboratory plays an important role in reporting and decision support to the patients.

Additionally, the report provides detailed initiatives that are being taken in the field of precision medicine. The market is classified into distinct regions including North America (U.S and Canada), Europe (Germany, France, Spain, Italy, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia) and rest of the world. United States generated revenue of US$ 17.9 billion in 2019. However, APAC region is expected to witness the highest CAGR growth of 11.27% during the forecast period 2020-2026.

Hoffmann-La Roche, Eli Lilly and Company, NeoGenomics Laboratories, Novartis, Teva Pharmaceutical, Thermo Fisher Scientific, Quest Diagnostics, Abbott Laboratories, NanoString Technologies, and AstraZeneca are some of the prominent players operating in the global precision medicine market. Several M&A’s along with partnerships have been undertaken by these players to develop precision medicine.

Global Precision Medicine Market Segmentation

Market Insight, by Technology Type

Big Data Analytics

Bioinformatics

Gene Sequencing

Drug Discovery

Companion Diagnostics

Other Products

Market Insight, by Application

Oncology

Respiratory Diseases

Central Nervous System Disorder

Immunology

Genetic Diseases

Others

Market Insight, by End-User

Hospitals & Clinics

Pharmaceuticals

Diagnostic Companies

Healthcare-IT Firms

Others

Market Insight, by Region

North America

United States

Canada

Rest of North America

Europe

Italy

Spain

France

Germany

United Kingdom

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

Rest of Asia-Pacific

Rest of World

Top Company Profiles

Hoffmann-La Roche

Medtronic

Qiagen

Illumina

Abbott Laboratories

GE Healthcare

NanoString Technologies

BioMérieux SA

Danaher Corporation

AstraZeneca

Feel free to contact us for any queries – https://univdatos.com/request_form/form/331

The precision Medicine Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

UnivDatos Market Insights (UMI) Latest Research Report –

Plant-Based Food Market — Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019–2025

Frozen Food Market — Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020

Hand Sanitizer Market Size Worth US$ 15.3 Billion by 2026

Critical Care Equipment Market to Reach US$ 38 Billion by 2026

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Web: https://univdatos.com

Ph: +91 7838604911

Comments

Popular posts from this blog

Renewable Energy Certificate Market: Analysis by Size, Share, Growth, Trends & Forecast 2030

  Renewable Energy Certificates: Powering a Sustainable Future The Renewable Energy Certificate (REC) market is surging, expected to reach a value of USD 87.2 billion by 2030 at a CAGR of 26.39%. This growth is fueled by a global shift towards clean energy: Government Policies: Governments worldwide are implementing policies and incentives to promote renewable energy and RECs as a way to achieve sustainability goals. Climate Change Concerns: Growing awareness of climate change is driving demand for cleaner energy sources and RECs as a way to offset carbon footprints. Technological Advancements: Advances in renewable energy technology have made it more cost-effective, reducing REC prices and making them a viable option for businesses and consumers. Sustainability-Conscious Consumers: Consumers are increasingly seeking products and services that align with their eco-friendly values, boosting the voluntary REC mar...

Offshore Hydropower Market: Analysis by Size, Share, Growth, Trends & Forecast 2030

  Harnessing the Ocean's Power: Offshore Hydropower Market Poised for Growth The offshore hydropower market is experiencing a surge, projected to reach a value of USD 6.2 billion by 2030 at a CAGR of 7.5%. This growth is driven by a global push for clean energy solutions: Combating Climate Change: Fossil fuels are a major culprit behind climate change. Offshore hydropower offers a clean alternative with minimal carbon footprint during operation. Sustainable Energy Future: By harnessing the vast power of the ocean tides and waves, this technology can play a crucial role in a sustainable energy future. Limited Freshwater Resources: Traditional hydropower dams are geographically restricted. Offshore hydropower offers a solution for island nations and countries with limited freshwater resources. Unlock Insights: Receive a Sample Research Report on the Offshore Hydropower Market: https://univdatos.com/get-a-free-sample-form-p...

Tire Derived Fuel Market: Analysis by Size, Share, Growth, Trends & Forecast 2030

  Used Tires Get a Second Life: Tire-Derived Fuel Market Driven by Sustainability and Waste Reduction The tire-derived fuel (TDF) market is gaining traction as a sustainable solution for managing a growing global waste problem – used tires. Expected to reach USD 4.4 billion by 2030 at a CAGR of 4.6%, this market is driven by several key trends: Environmental Benefits Take Center Stage Waste Reduction: Stockpiling used tires in landfills takes up valuable space and poses environmental hazards. TDF offers a way to transform this waste into a usable fuel source, promoting a circular economy. Sustainable Alternative: Fossil fuel dependence is a major environmental concern. TDF offers a greener alternative with lower sulfur oxide emissions compared to coal, contributing to cleaner air. Unlock Insights: Receive a Sample Research Report on the Tire Derived Fuel Market: https://univdatos.com/get-a-free-sample-form-php/?product_id=57098 Asia ...